JAZZPHARMA HA CONSEGUIDO DETENER EL DESPLOME BURSATIL DEL ÚLTIMO MES EN QUE SE DEJÓ MAS DE 40$ ... GRACIAS A : Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer .